Company	Price	Valuation					Profitability					Cash & leverage					Quality				Rating
		P/E	P/B	P/S	EV / EBITDA	DCF upside	Gross margin	Operating margin	Net margin	ROE	ROIC	FCF yield	Debt / equity	Net debt / EBITDA	Interest coverage	Current ratio	Dividend yield	Piotroski (0-9)	Altman Z	Rating score (1-5)
ALM.MCthis companyAlmirall, S.A.	€10.52	58.36×	1.85×	2.49×	12.62×	30.9%	41.2%	6.1%	4.2%	3.1%	2.1%	4.9%	0.23×	0.02×	3.79×	2.04×	0.9%	7	2.93	3	B+
FAE.MCFaes Farma, S.A.	€4.92	19.85×	2.16×	2.63×	18.65×	-29.6%	37.4%	11.9%	13.0%	10.7%	5.7%	3.9%	0.55×	2.87×	11.51×	2.61×	3.5%	5	2.82	4	A
ORY.MCOryzon Genomics S.A.	€2.39	-88.86×	2.19×	0×	-34.19×	-90.8%	0.0%	0.0%	0.0%	-2.5%	-2.2%	-1.0%	0.11×	2.61×	-10.55×	1.95×	0.0%	2	5.2	2	C+
PHM.MCPharma Mar, S.A.	€67.30	17.42×	5.12×	5.82×	27.34×	-26.6%	94.5%	18.2%	33.9%	29.8%	12.8%	3.4%	0.2×	0.65×	16.38×	3.02×	1.1%	8	6.88	4	A-
RJF.MCLaboratorio Reig Jofre, S.A.	€2.55	41.65×	0.96×	0.63×	9.75×	-3.6%	24.7%	1.7%	1.5%	2.3%	1.4%	-6.6%	0.45×	2.89×	2.99×	1.54×	0.0%	2	1.69	2	B-
ROVI.MCLaboratorios Farmaceuticos Rovi, S.A.	€69.05	23.09×	4.89×	4.37×	16.07×	2.2%	60.7%	23.3%	18.9%	21.1%	16.5%	3.7%	0.18×	0.12×	60.84×	3.14×	1.5%	6	7.18	4	A-
Peer median	—	19.85×	2.19×	2.63×	16.07×	-26.6%	37.4%	11.9%	13.0%	10.7%	5.7%	3.4%	0.2×	2.61×	11.51×	2.61×	1.1%	5	5.2	4	—